Ruben D Carrasquilla- Meléndez, Antonio Oyola-Yepes, Jonathan J Rodríguez- Blanco, Ángel Castro-Dager, Rafael Almeida-Pérez, Gina M De la Rosa- Manjarrez, Fernando E Orozco-Gómez, María Cristina MartínezÁvila*, and Miguel David Quintero- Consuegra
Retinoblastoma (RB) is the most common eye neoplasm in childhood, accounting for 2.5% to 4% of all pediatric cancers. Recent approaches to treat RB include localized administration of chemotherapy, such as super-selective ophthalmic artery chemotherapy. Although localized chemotherapy aims that minimize systemic side effects, some adverse cardio-respiratory reactions have been described as associated with this therapy. Our case report describes the cardiorespiratory severe events presented secondary to super-selective chemotherapy of the ophthalmic artery, to which we must be prepared to avoid fatal outcomes.
